Benitec Biopharma Inc (BNTC)
10.66
+0.26
(+2.50%)
USD |
NASDAQ |
Nov 15, 16:00
10.66
0.00 (0.00%)
After-Hours: 19:54
Benitec Biopharma Shareholders Equity (Quarterly): 47.25M for June 30, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
Date | Value |
---|---|
June 30, 2024 | 47.25M |
March 31, 2024 | 11.50M |
December 31, 2023 | 15.47M |
September 30, 2023 | 22.31M |
June 30, 2023 | 0.202M |
March 31, 2023 | 4.713M |
December 31, 2022 | 8.994M |
September 30, 2022 | 14.61M |
June 30, 2022 | 2.882M |
March 31, 2022 | 7.52M |
December 31, 2021 | 10.84M |
September 30, 2021 | 15.48M |
June 30, 2021 | 20.01M |
March 31, 2021 | 10.93M |
December 31, 2020 | 14.62M |
September 30, 2020 | 7.736M |
June 30, 2020 | 10.24M |
Date | Value |
---|---|
June 30, 2019 | 16.59M |
December 31, 2018 | 19.80M |
June 30, 2018 | 13.77M |
March 31, 2018 | 10.13M |
December 31, 2017 | 12.43M |
September 30, 2017 | 14.73M |
June 30, 2017 | 16.53M |
March 31, 2017 | 18.35M |
December 31, 2016 | 13.36M |
September 30, 2016 | 15.05M |
June 30, 2016 | 14.07M |
March 31, 2016 | 19.02M |
December 31, 2015 | 19.87M |
June 30, 2015 | 18.31M |
December 31, 2014 | 24.23M |
June 30, 2014 | 22.48M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
0.202M
Minimum
Jun 2023
47.25M
Maximum
Jun 2024
13.25M
Average
10.93M
Median
Mar 2021
Shareholders Equity (Quarterly) Benchmarks
NovaBay Pharmaceuticals Inc | 1.072M |
Palatin Technologies Inc | -0.1115M |
iBio Inc | 21.32M |
Theriva Biologics Inc | 27.65M |
Oragenics Inc | 1.326M |
Shareholders Equity (Quarterly) Related Metrics
Total Assets (Quarterly) | 52.21M |
Total Liabilities (Quarterly) | 4.962M |